{ "items" : [
    { "id" : "http://dbpedia.org/resource/Dharmacon,_Inc."
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Dharmacon was founded in 1995 by Stephen Scaringe as Dharmacon Research to develop and commercialize a new technology for RNA oligonucleotide synthesis.  The original Dharmacon focus and vision was to develop 2'-ACE RNA technology as the standard for RNA synthesis and to advance RNA oligo-dependent applications and technologies.  When RNA interference (RNAi) emerged in the late 1990s, Dharmacon was poised to provide RNAi-related products to the multitude of academic and industry researchers." ] ,
        "http://xmlns.com/foaf/0.1/name" : [ "GE Healthcare" ] ,
        "http://dbpedia.org/ontology/foundingYear" : [ "1995Z" ] ,
        "http://dbpedia.org/ontology/industry" : [ "http://dbpedia.org/resource/Biotechnology" ] ,
        "http://dbpedia.org/ontology/keyPerson" : [ "http://dbpedia.org/resource/General_manager",
          "http://dbpedia.org/resource/Mike_Deines" ] ,
        "http://dbpedia.org/ontology/location" : [ "http://dbpedia.org/resource/Lafayette,_Colorado" ] ,
        "http://dbpedia.org/ontology/numberOfEmployees" : [ 150 ] ,
        "http://dbpedia.org/ontology/product" : [ "http://dbpedia.org/resource/RNA_interference",
          "http://dbpedia.org/resource/Small_interfering_RNA",
          "http://dbpedia.org/resource/Transfection",
          "http://dbpedia.org/resource/Small_hairpin_RNA",
          "http://dbpedia.org/resource/ORFs",
          "http://dbpedia.org/resource/Complementary_DNA",
          "http://dbpedia.org/resource/MicroRNA" ] ,
        "http://dbpedia.org/ontology/type" : [ "http://dbpedia.org/resource/Subsidiary"] } } }
